They reported that in donor-recipient cycles a GnRH agonist trigger resulted in a lower incidence of OHSS in donors when compared to an hCG trigger, with no difference in recipient live birth rates (72). Here, GNRH1 is linked to ovarian hyperstimulation syndrome.